Kathryn E Pearce
Overview
Explore the profile of Kathryn E Pearce including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
305
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Phan M, Gomes M, Stinnett V, Morsberger L, Hoppman N, Pearce K, et al.
Biomedicines
. 2024 Mar;
12(3).
PMID: 38540211
Complex structural chromosome abnormalities such as chromoanagenesis have been reported in acute myeloid leukemia (AML). They are usually not well characterized by conventional genetic methods, and the characterization of chromoanagenesis...
2.
Pitel B, Zepeda-Mendoza C, Sachs Z, Tang H, Shivaram S, Sharma N, et al.
Blood Cancer J
. 2023 Sep;
13(1):138.
PMID: 37673866
No abstract available.
3.
Gagnon M, Midthun S, Fangel J, Schuh C, Luoma I, Pearce K, et al.
Am J Clin Pathol
. 2023 Sep;
161(1):60-70.
PMID: 37658775
Objectives: Fluorescence in situ hybridization (FISH) for plasma cell neoplasms (PCNs) requires plasma cell (PC) identification or purification strategies to optimize results. We compared the efficacy of cytoplasmic immunoglobulin FISH...
4.
Gagnon M, Pearce K, Greipp P, Xu X, Hoppman N, Ketterling R, et al.
Blood Cancer J
. 2021 Nov;
11(11):184.
PMID: 34819491
No abstract available.
5.
Horna P, Pearce K, Ketterling R, Shi M, Peterson J
Am J Clin Pathol
. 2021 Sep;
157(2):286-292.
PMID: 34528680
Objectives: Prognostically relevant chromosomal abnormalities in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) are routinely identified by fluorescence in situ hybridization (FISH) on peripheral blood or bone marrow specimens. We studied...
6.
Chen J, Hou Y, Roskin K, Arber D, Bangs C, Baughn L, et al.
Blood Adv
. 2021 Sep;
5(17):3492-3496.
PMID: 34505882
The basis for acquired resistance to JAK inhibition in patients with JAK2-driven hematologic malignancies is not well understood. We report a patient with a myeloproliferative neoplasm (MPN) with a BCR...
7.
Sharma N, Smadbeck J, Abdallah N, Zepeda-Mendoza C, Binder M, Pearce K, et al.
Clin Cancer Res
. 2021 Jul;
27(19):5430-5439.
PMID: 34233962
Purpose: Structural variants (SV) of the MYC gene region are common in multiple myeloma and influence disease progression. However, the prognostic significance of different MYC SVs in multiple myeloma has...
8.
Dalland J, Smadbeck J, Sharma N, Meyer R, Pearce K, Greipp P, et al.
Genes Chromosomes Cancer
. 2021 Jun;
60(10):678-686.
PMID: 34124820
Plasma cell neoplasms (PCN) and mantle cell lymphoma (MCL) can both harbor t(11;14)(q13;q32) (CCND1/IGH), usually resulting in cyclin D1 overexpression. In some cases, particularly at low levels of disease, it...
9.
Guenzel A, Smadbeck J, Golden C, Williamson C, Benevides Demasi J, Vasmatzis G, et al.
Ann Diagn Pathol
. 2021 May;
53:151761.
PMID: 33991782
The t(5;14)(q31.1;q32.1) associated with B-lymphoblastic leukemia/lymphoma (B-ALL/LBL) is a rare, recurrent genetic abnormality recognized as a distinct entity by the 2017 World Health Organization (WHO) classification. In these cases, the...
10.
Pitel B, Sharma N, Zepeda-Mendoza C, Smadbeck J, Pearce K, Cook J, et al.
Blood Cancer J
. 2021 Feb;
11(2):18.
PMID: 33563889
No abstract available.